MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$34,099K
EPS
-$0.8
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
25,931
25,626
19,911*
20,012
General and administrative
9,396
7,609
3,703*
5,981
Total operating expenses
35,327
33,235
23,613
25,993
Loss from operations
-35,327
-33,235
-23,613*
-25,993
Interest income
1,286
760
50*
419
Change in fair value of the tranche rights
-
-
0*
0
Other income (expense), net
-58
-113
4,991*
-5
Total other income
1,228
647
5,041*
414
Net loss
-34,099
-32,588
-18,573
-25,579
Basic EPS
-0.8
-1.08
-0.132
-0.13
Diluted EPS
-0.8
-1.08
-0.132
-0.13
Basic Average Shares
42,513,839
30,136,324
140,991,124
193,897,764
Diluted Average Shares
42,513,839
30,136,324
140,991,124
193,897,764
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Interest income
$1,286K
(433.61%↑ Y/Y)
Net loss
-$34,099K
(-27.14%↓ Y/Y)
Total other income
$1,228K
(366.92%↑ Y/Y)
Other income
(expense), net
-$58K
(-363.64%↓ Y/Y)
Loss from operations
-$35,327K
(-30.44%↓ Y/Y)
Total operating
expenses
$35,327K
(30.44%↑ Y/Y)
Research and development
$25,931K
(21.35%↑ Y/Y)
General and
administrative
$9,396K
(64.44%↑ Y/Y)
Buy us a coffee
IMMUNIC, INC. (IMUX)
IMMUNIC, INC. (IMUX)